Let’s determine which COVID-19 test is right for you.
Get a Pixel by Labcorp COVID-19 Home Test Collection Kit at $0 Upfront Cost for Eligible Individuals With Insurance
Find out if you currently have COVID-19 without leaving home.
CONVENIENT COVID-19 TESTING OPTIONS
Keep yourself and your loved ones safe by testing for COVID-19
With over 50 million COVID-19 tests performed since the start of the pandemic, our tests continue to detect all of the variant changes being tracked by the CDC, including the Delta variant.
There are four ways to get the trusted Labcorp COVID-19 PCR test.
Tracking COVID-19 Variants
Labcorp has been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants. We have been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19. Our tests remain effective against variants like Omicron and Delta. This is because they are designed to identify segments of the genetic code that are the least likely to mutate. For more information on variants, see our Viral Variation 101 post or read our Guide to Variants.
Total number of samples sequenced
402,000 as of June 30, 2022
Data covers the U.S. including the District of Columbia and Puerto Rico
Labcorp PCR Test performance confirmed
Alpha (B.1.1.7, Q.1-Q.8)
Beta (B.1.351, B.1.351.2, B.1.351.3)
Epsilon (B.1.427, B.1.429)
Gamma (P.1, P.1.1, P.1.2)
Omicron (B.1.1.529, BA.2, BA.4, BA4.6, BA.5)
Labcorp's COVID-19 Testing Stats
COVID-19 PCR Testing
Average Time to Result
From Specimen Pickup
COVID-19 PCR Testing
Molecular Tests Performed
COVID-19 Antibody Testing
Antibody Tests Performed
Stats updated as of June 30, 2022. COVID-19 volumes are U.S. and Canada volumes and are consistent with the figures provided in the company’s quarterly financial results. Prior volumes published on the website were U.S. only. Future COVID-19 test volumes will be updated quarterly after the release of Labcorp’s quarterly earnings results.
How can I make a difference?
COVID-19 Clinical Trials Connect
Labcorp Drug Development is running multiple COVID-19 research studies and invites you to help in the fight against COVID-19.
See How Labcorp Performs the COVID-19 Test
You can get tested through your healthcare provider, have them request a Labcorp COVID-19 home collection kit, or request one yourself by visiting Labcorp OnDemand.
Latest & Previous News
Media Statement: Labcorp Receives FDA Emergency Use Authorization for First COVID-19 Test to Identify Specific SARS-CoV-2 Lineages
BURLINGTON, N.C., June 14, 2022 — On Friday, June 10, 2022, Labcorp, a global life sciences company, received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its VirSeq SARS-CoV-2 NGS (next-generation sequencing) Test on the PacBio Sequel II sequencing system.Read more about Media Statement: Labcorp Receives FDA Emergency Use Authorization for First COVID-19 Test to Identify Specific SARS-CoV-2 Lineages
Previous News Releases and Media Statements
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
BURLINGTON, N.C., May 18, 2022 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often seen in children.
Labcorp Now Offers Observed Collection for COVID-19 PCR Testing in Over 500 Locations Nationwide, with Plans to Expand to More Than 1,000 Locations
BURLINGTON, N.C., Nov. 30, 2021 — Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers (PSCs) nationwide for people without symptoms or known exposure. By mid-December, the company plans to further expand the COVID-19 PCR test collection service to over 1,000 locations.
Labcorp Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection
BURLINGTON, N.C., Oct. 1, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined home collection kit that detects COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with COVID-19 or if asked to be tested by a health care provider.
BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19.
Labcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral Surveillance
Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp (NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country.
The North Carolina Department of Health and Human Services today announced the state is expanding availability of its at-home COVID-19 test collection. Any North Carolina resident may receive a Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit that is shipped overnight directly to their homes at no cost. Tests can be used on people age 2 and up.